Apotheke des Universitätsklinikums


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

4. Ringversuch Arzneimittelinformation der ADKA. Frage und Musterantwort (2021) Strobach D, Blassmann U, Klausner S, Krebs S, Langebrake C, Querbach C, Schuhmacher C Journal article Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab (2021) Fischer S, Cohnen S, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Journal article Medication safety in intravenous therapy: A compatibility study of clonidine with drugs frequently used in intensive care (2021) Koller AK, Krebs S, Dörje F Journal article Trastuzumab Biosimilars in the Therapy of Breast Cancer – “Real World” Experiences from four Bavarian University Breast Centres (2020) Hester A, Gaß P, Fasching P, Kraemer AK, Ettl J, Diessner J, Woeckel A, et al. Journal article Medication safety in intravenous therapy: A compatibility study and analysis of reaction products of dihydralazine and metamizole (2020) Koller AK, Fischer O, Krebs S, Heinrich M, Dörje F Journal article 3rd round robin test of drug information of the ADKA: Art of asking questions, sample answers and quality of bibliographical references (2020) Strobach D, Blassmann U, Gundl S, Krebs S, Langebrake C, Querbach C, Schuhmacher C Journal article Akustische Levitation: Aktivitätsverlust von Enzymen während der Einzeltropfentrocknung (2020) Prihoda F Journal article Assessing the quality of drug information provided by hospital pharmacies using a fictitious enquiry and simulated real-life conditions (2020) Strobach D, Blassmann U, Gundl S, Krebs S, Querbach C, Schuhmacher C, Langebrake C Journal article Efficacy, safety, and pharmacokinetics after switching from infliximab originator to biosimilar SB2 in inflammatory bowel disease patients: A long-term observational, prospective cohort study (2020) Fischer S, Mesfin SE, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Conference contribution New Oral Anti-Cancer Drugs and Medication Safety (2019) Schlichtig K, Duerr P, Dörje F, Fromm M Journal article, Review article